85-1452-13 Phospholipase A2, Secretory, Group IIA, Recombinant, Human (PLA2, sPLA2-IIA) 2ug P4074-06E2
特徴
- Phospholipase A2 (PLA2) catalyzes the hydrolysis of the sn-2 position of membrane glycerophospholipids to liberate arachidonic acid (AA), a precursor of eicosanoids including prostaglandins and leukotrienes. The same reaction also produces lysophosholipids, which represent another class of lipid mediators. The secretory PLA2 (sPLA2) family, in which 10 isozymes have been identified, consists of lowmolecular weight, Ca2+-requiring secretory enzymes that have been implicated in a number of biological processes, such as modification of eicosanoid generation, inflammation, and host defense. This enzyme has been proposed to hydrolyze phosphatidylcholine (PC) in lipoproteins to liberate lyso- PC and free fatty acids in the arterial wall, thereby facilitating the accumulation of bioactive lipids and modified lipoproteins in atherosclerotic foci. In mice, sPLA2 expression significantly influences HDL particle size and composition and demonstrate that an induction of sPLA2 is required for the decrease in plasma HDL cholesterol in response to inflammatory stimuli. Instillation of bacteria into the bronchi was associated with surfactant degradation and a decrease in large:small ratio of surfactant aggregates in rats. sPLA2-IIA can exert beneficial action in the context of infectious diseases since recent studies have shown that this enzyme exhibits potent bactericidal effects. Induction of the synthesis of sPLA2-IIA is generally initiated by endotoxin and a limited number of cytokines via paracrine and/or autocrine processes.
- The Recombinant Human Secreted Phospholipase A2-IIA is manufactured with N-terminal fusion of HisTag. The Recombinant Human Secreted Phospholipase A2-IIA His-Tagged Fusion Protein is 15.8kD containing 124aa residues of the human secreted phospholipase A2-IIA and 16 additional amino acid residues – HisTag.
- Amino Acid Sequence:MRGSHHHHHH GMASHMNLVN FHRMIKLTTG KEAALSYGFY GCHCGVGGRG SPKDATDRCC VTHDCCYKRL EKRGCGTKFL SYKFSNSGSR ITCAKQDSCR SQLCECDKAA ATCFARNKTT YNKKYQYYSN KHCRGSTPRC
- Specificity:The amino acid sequence of the Recombinant Human sPLA2-IIA is 100% homologous to the amino acid sequence of the human Secreted Phospholipase A2-IIA.
- Applications:Suitable for use in Western Blot. Other applications not tested.
- Recommended Dilutions:Optimal dilutions to be determined by the researcher.
- Storage and Stability:Lyophilized and reconstituted products are stable for 6 months after receipt at -20°C. Reconstitute with 0.1M Acetate buffer, pH 4.. Aliquot to avoid repeated freezing and thawing. Store at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
仕様
- Size:2ug
- Source Antigen:Recombinant, E. coli
- Grade:Highly Purified
- Purity:≥95% (SDS-PAGE)
- Form:Supplied as a lyophilized powder from 0.05M acetate buffer, pH 4.0. Add 200ul of 0.1M Acetate buffer pH4 and let the lyophilized pellet dissolve completely. For conversion into higher pH value, we recommend intensive dilution by relevant buffer to a concentration of 10 ug/ml. In higher concentrations the solubility of this antigen is limited.
- Molecular Weight Non Ab:15.8
- EU Commodity Code:30021019
- この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
- 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
- 【試薬に関するお問合せ】
- アズワン株式会社 試薬・プロセス材料グループ
- TEL:06-6447-8641
- FAX:06-6447-8642
- E-mail:[email protected]
商品のバリエーション (サイズ違い・スペック違い・オプション品など)
| 商品イメージ | アズワン品番 商品名 |
|---|---|
|
85-1452-14
Phospholipase A2, Secretory, Group IIA, Recombinant, Human (PLA2, sPLA2-IIA) 10ug
|
|
|
85-1452-13
Phospholipase A2, Secretory, Group IIA, Recombinant, Human (PLA2, sPLA2-IIA) 2ug
|
よくあるご質問(FAQ)
掲載カタログ情報
| 掲載カタログ名 | 掲載ページ |
|---|





